Literature DB >> 29106745

Demonstration of velocity selective myocardial arterial spin labeling perfusion imaging in humans.

Terrence R Jao1, Krishna S Nayak2.   

Abstract

PURPOSE: Transit delay is a potential source of error in cardiac arterial spin-labeled (ASL) in heart failure or with collateral circulation. This study demonstrates the feasibility of using transit delay insensitive velocity selective ASL and compares its performance with flow-sensitive alternating inversion recovery (FAIR) ASL.
METHODS: Velocity selective labeling was achieved using an adiabatic BIR8 preparation. FAIR and velocity-selective ASL (VSASL) with various velocity cutoffs (VC  = 10-40 cm/s) and labeling directions (anterior-posterior X, lateral-septal Y, and apical-basal Z) were carried out in 10 healthy volunteers (1F/9M age 23-30 y). Myocardial blood flow (MBF) and temporal signal-to-noise (TSNR) were measured.
RESULTS: VSASL sensitivity to perfusion decreased with increasing VC . At low VC (<5 cm/s), spurious labeling of myocardium occurs and overestimates MBF. MBF measured with FAIR (1.12 ± 0.26 ml/g/min) and VASL (1.26 ± 0.27 ml/g/min) at VC of 10 cm/s in Z were comparable (TOST with difference of 0.30 ml/g/min, P = 0.049). TSNR was 2.8 times larger using FAIR (13.62 ± 5.25) than in VSASL (4.87 ± 1.58). VSASL was insensitive to perfusion in the Y direction. X and Z performed similarly with TSNR of 4.17 ± 2.32 and 3.97 ± 0.56, respectively.
CONCLUSION: VSASL is a promising alternative to FAIR ASL in the heart and is well suited for scenarios when transit delays are long. Magn Reson Med 80:272-278, 2018.
© 2017 International Society for Magnetic Resonance in Medicine. © 2017 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  arterial spin labeling; cardiovascular magnetic resonance; myocardial blood flow; myocardial perfusion imaging; transit delay; velocity selective labeling

Mesh:

Substances:

Year:  2017        PMID: 29106745      PMCID: PMC6598714          DOI: 10.1002/mrm.26994

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  6 in total

1.  Improved velocity-selective labeling pulses for myocardial ASL.

Authors:  Vanessa Landes; Ahsan Javed; Terrence Jao; Qin Qin; Krishna Nayak
Journal:  Magn Reson Med       Date:  2020-03-15       Impact factor: 4.668

2.  Exploring label dynamics of velocity-selective arterial spin labeling in the kidney.

Authors:  Isabell K Bones; Suzanne L Franklin; Anita A Harteveld; Matthias J P van Osch; Sophie Schmid; Jeroen Hendrikse; Chrit Moonen; Marijn van Stralen; Clemens Bos
Journal:  Magn Reson Med       Date:  2021-02-04       Impact factor: 4.668

3.  Subject-specific optimization of background suppression for arterial spin labeling magnetic resonance imaging using a feedback loop on the scanner.

Authors:  Kirsten Koolstra; Marius Staring; Paul de Bruin; Matthias J P van Osch
Journal:  NMR Biomed       Date:  2022-05-09       Impact factor: 4.478

Review 4.  Velocity-selective arterial spin labeling perfusion MRI: A review of the state of the art and recommendations for clinical implementation.

Authors:  Qin Qin; David C Alsop; Divya S Bolar; Luis Hernandez-Garcia; James Meakin; Dapeng Liu; Krishna S Nayak; Sophie Schmid; Matthias J P van Osch; Eric C Wong; Joseph G Woods; Greg Zaharchuk; Moss Y Zhao; Zungho Zun; Jia Guo
Journal:  Magn Reson Med       Date:  2022-07-12       Impact factor: 3.737

5.  Influence of labeling parameters and respiratory motion on velocity-selective arterial spin labeling for renal perfusion imaging.

Authors:  Isabell K Bones; Suzanne L Franklin; Anita A Harteveld; Matthias J P van Osch; Jeroen Hendrikse; Chrit Moonen; Marijn van Stralen; Clemens Bos
Journal:  Magn Reson Med       Date:  2020-03-17       Impact factor: 4.668

6.  Myocardial arterial spin labeling in systole and diastole using flow-sensitive alternating inversion recovery with parallel imaging and compressed sensing.

Authors:  Markus Henningsson; Carl-Johan Carlhäll; Johan Kihlberg
Journal:  NMR Biomed       Date:  2020-11-04       Impact factor: 4.478

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.